ADC Therapeutics SA (ADCT)
4.12
+0.08
(+1.98%)
USD |
NYSE |
May 15, 14:35
ADC Therapeutics Total Assets (Quarterly): 307.97M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 307.97M |
December 31, 2023 | 354.78M |
September 30, 2023 | 466.90M |
June 30, 2023 | 507.30M |
March 31, 2023 | 467.67M |
December 31, 2022 | 490.86M |
September 30, 2022 | 531.76M |
June 30, 2022 | 520.46M |
March 31, 2022 | 581.89M |
December 31, 2021 | 617.97M |
Date | Value |
---|---|
September 30, 2021 | 637.98M |
June 30, 2021 | 464.39M |
March 31, 2021 | 461.70M |
December 31, 2020 | 513.69M |
September 30, 2020 | 521.53M |
June 30, 2020 | 373.84M |
December 31, 2019 | 137.68M |
June 30, 2019 | 200.84M |
December 31, 2018 | 150.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
137.68M
Minimum
Dec 2019
637.98M
Maximum
Sep 2021
453.29M
Average
479.27M
Median
Total Assets (Quarterly) Benchmarks
Roche Holding AG | 107.71B |
Novartis AG | 94.33B |
AC Immune SA | 185.40M |
CRISPR Therapeutics AG | 2.439B |
Addex Therapeutics Ltd | 5.526M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 502.42M |
Shareholders Equity (Quarterly) | -194.45M |
Debt to Equity Ratio | -0.5823 |
Current Ratio | 4.608 |
Net Debt Paydown Yield | -0.19% |